Pfizer Announces Presentation of Data from a Phase 2 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older

April 13, 2019 – Pfizer Inc. (NYSE: PFE) announced today the presentation of data from a Phase 2 study of its 20-valent pneumococcal conjugate vaccine (20vPnC) candidate, PF-06482077, being investigated for the prevention of invasive

How to Do a Perfect Goblet Squat

The goblet squat is a core training staple — but are you sure you’re even doing the exercise correctly? For this basic gym necessity, you shouldn’t settle for anything other than perfect form—especially because it’s